tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SRPT Stock Latest News

Sarepta Stock (SRPT) Rallies on FDA Nod for Broader Gene Therapy Use
Market NewsSarepta Stock (SRPT) Rallies on FDA Nod for Broader Gene Therapy Use
2d ago
SRPT
Biotech stocks rise following Prasad exit from FDA
PremiumThe Fly
Biotech stocks rise following Prasad exit from FDA
2d ago
BHVN
CAPR
Unusually active option classes on open July 30th
PremiumThe Fly
Unusually active option classes on open July 30th
2d ago
HUM
VFC
Roche says 760 ambulatory DMD patients treated with Elevidys with no deaths
PremiumThe Fly
Roche says 760 ambulatory DMD patients treated with Elevidys with no deaths
3d ago
CHRO
SRPT
Sarepta price target raised to $17 from $12 at TD Cowen
PremiumThe Fly
Sarepta price target raised to $17 from $12 at TD Cowen
3d ago
SRPT
Roche says set to resume shipments of Sarepta’s Elevidys outside U.S.
PremiumThe FlyRoche says set to resume shipments of Sarepta’s Elevidys outside U.S.
3d ago
CHRO
SRPT
Barclays upgrades Sarepta to Equal Weight with worst-case ‘off the table’
Premium
The Fly
Barclays upgrades Sarepta to Equal Weight with worst-case ‘off the table’
3d ago
SRPT
Sarepta upgraded to Equal Weight from Underweight at Barclays
Premium
The Fly
Sarepta upgraded to Equal Weight from Underweight at Barclays
3d ago
SRPT
Sarepta upgraded, Tapestry downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Sarepta upgraded, Tapestry downgraded: Wall Street’s top analyst calls
3d ago
CF
EW
Morning Movers: Boeing, P&G advance after earnings
PremiumThe Fly
Morning Movers: Boeing, P&G advance after earnings
3d ago
BA
PG
Video: Boeing results, dealmaking highlight busy morning
PremiumThe Fly
Video: Boeing results, dealmaking highlight busy morning
3d ago
BA
BKR
Sarepta price target raised to $15 from $11 at Piper Sandler
PremiumThe Fly
Sarepta price target raised to $15 from $11 at Piper Sandler
3d ago
SRPT
Sarepta price target raised to $20 from $15 at Morgan Stanley
PremiumThe FlySarepta price target raised to $20 from $15 at Morgan Stanley
3d ago
SRPT
Sarepta price target raised to $40 from $25 at BMO Capital
Premium
The Fly
Sarepta price target raised to $40 from $25 at BMO Capital
3d ago
SRPT
Sell Rating for Sarepta Therapeutics Amidst Uncertainty and Financial Risks
Premium
Ratings
Sell Rating for Sarepta Therapeutics Amidst Uncertainty and Financial Risks
3d ago
SRPT
Sarepta price target raised to $5 from 0c at H.C. Wainwright
PremiumThe Fly
Sarepta price target raised to $5 from 0c at H.C. Wainwright
3d ago
SRPT
Sarepta initiated with a Market Perform at Bernstein
PremiumThe Fly
Sarepta initiated with a Market Perform at Bernstein
3d ago
SRPT
Sarepta upgraded to Outperform from Perform at Oppenheimer
PremiumThe Fly
Sarepta upgraded to Outperform from Perform at Oppenheimer
3d ago
SRPT
Sarepta upgraded to Neutral from Underweight at JPMorgan
PremiumThe Fly
Sarepta upgraded to Neutral from Underweight at JPMorgan
3d ago
SRPT
Closing Bell Movers: Sarepta surges as FDA may lift Elevidys shipments pause
PremiumThe FlyClosing Bell Movers: Sarepta surges as FDA may lift Elevidys shipments pause
4d ago
CR
BRO
Sarepta jumps 48% to $20.51 after FDA lifts Elevidys hold for some patients
Premium
The Fly
Sarepta jumps 48% to $20.51 after FDA lifts Elevidys hold for some patients
4d ago
SRPT
Sarepta trading resumes
Premium
The Fly
Sarepta trading resumes
4d ago
SRPT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >